2022 AAOS Annual Meeting: Opioid-Sparing Pain Management Protocol following Shoulder Arthroplasty Results in Less Opioid Consumption and Higher Satisfaction: A Prospective, Randomized Control Trial

A total of 78 patients were included in this randomized trial comparing an opioid-sparing and opioid-based pain protocol for pain management after total shoulder arthroplasty. Outcomes of interest included pain scores, opioid consumption, patient satisfaction, range of motion, patient-reported functional outcomes, complications, readmission and reoperation. Results revealed significantly lower opioid consumption up to 12 weeks post-operation, and higher patient satisfaction with pain management up to 6 weeks post-operation, in the opioid-sparing group. No differences in pain scores, range of motion, functional outcomes, complications, readmissions or reoperations were observed.